The FVB-huHER2 mouse, which is prone to the development of autochthonous mammary tumors driven by huHER2 expression, was used as a model with which to study active immunological strategies targeting the human HER2 molecule in a tolerant host. This evidence concerns the gene ERBB2 and breast cancer.